14 Jul 2016 08:34![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
Mon, 07th Jun 2021 10:11
(ShareCast News) - Avacta, biotherapeutics and research agent developer, reported on Wednesday it had identified three proteins which could be used to develop the first tests to diagnose early stages of the Zika virus. Avacta said it found three 'Affimer' proteins capable of binding to a form of sec
Read more(ShareCast News) - Avacta Group established what it saw as one of the last pieces in the management puzzle to get its products towards the market, appointing professors Terence Rabbitts, Paul Moss and Adrian Hayday to form the company's scientific advisory board on Monday. The AIM-traded developer o
Read more